Tata India Pharma And Healthcare Fund Regular Plan Growth

NORMAL RISK
Equity
Equity: Sectoral-Pharma
6M returns
-3.27 %
Current NAV
29.30
1M3M6M1Y3Y5YALL
Loading...
Min. SIP
5000
AUM
₹ 1183.7 Cr

Return Calculator

Amount per month5,000
Over the past
1Y
3Y
5Y
Return amount NA
Total Investment
60,000

Investment distribution

Sun Pharmaceutical Industries11.8 %
Aurobindo Pharma7.3 %
Cipla6.0 %
Apollo Hospitals Enterprise5.7 %
Lupin5.2 %
Fortis Healthcare5.1 %

Fund Manager

MS
Meeta Shetty
RS
Rajat Srivastava

Fund Information

Launched
11 Apr 2015(10 years ago)
Expense ratio2.17%
Exit LoadExit load of 0.25% if redeemed within 30 days.
Benchmark index
NIFTY Pharma TRI100%

Fund Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Copyright ⓒ 2024 Cherry. All rights reserved.
appstoreplaystore